Lv4
500 积分 2023-12-25 加入
Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017
5个月前
已完结
Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis
5个月前
已完结
Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World)
5个月前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
5个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
5个月前
已完结
Antibody-drug Conjugate Targets, Drugs, and Linkers
6个月前
已完结
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer
6个月前
已完结
Contemporary radiotherapy: present and future
6个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
6个月前
已完结
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens
6个月前
已完结
皖公网安备34019202002308
